Literature DB >> 10489335

The interferon-inducible 204 gene, a member of the Ifi 200 family, is not involved in the antiviral state induction by IFN-alpha, but is required by the mouse cytomegalovirus for its replication.

L Hertel1, M De Andrea, B Azzimonti, A Rolle, M Gariglio, S Landolfo.   

Abstract

To examine whether Ifi 200 genes are involved in antiviral state induction by IFNs we expressed mutant forms capable of inactivating the endogenous p204 and analyzed replication of both RNA and DNA viruses following IFN-alpha treatment. Inactivation of p204 does not impair replication of vesicular stomatitis virus, encephalomyocarditis virus, ectromelia virus, and herpes simplex virus 1 and does not alter an IFN-alpha induced antiviral state. By contrast, in cells lacking functional p204, mouse cytomegalovirus (MCMV) replication is strongly inhibited and is not further modulated by IFN-alpha. These results suggest that p204, a member of the Ifi 200 gene family, is not involved in the IFN-alpha-induced antiviral activity against some RNA or DNA viruses, but is required by MCMV for its replication. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10489335     DOI: 10.1006/viro.1999.9885

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins.

Authors:  Chuan-ju Liu; Bo Ding; Hong Wang; Peter Lengyel
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

2.  MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon.

Authors:  C j Liu; H Wang; Z Zhao; S Yu; Y B Lu; J Meyer; G Chatterjee; S Deschamps; B A Roe; P Lengyel
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein.

Authors:  Ileana M Cristea; Nathaniel J Moorman; Scott S Terhune; Christian D Cuevas; Erin S O'Keefe; Michael P Rout; Brian T Chait; Thomas Shenk
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 4.  Recognition of herpesviruses by the innate immune system.

Authors:  Søren R Paludan; Andrew G Bowie; Kristy A Horan; Katherine A Fitzgerald
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

Review 5.  Cytomegalovirus immune evasion of myeloid lineage cells.

Authors:  Melanie M Brinkmann; Franziska Dağ; Hartmut Hengel; Martin Messerle; Ulrich Kalinke; Luka Čičin-Šain
Journal:  Med Microbiol Immunol       Date:  2015-03-17       Impact factor: 3.402

Review 6.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

Review 7.  The p200 family protein p204 as a modulator of cell proliferation and differentiation: a brief survey.

Authors:  Peter Lengyel; C J Liu
Journal:  Cell Mol Life Sci       Date:  2009-11-18       Impact factor: 9.261

8.  Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability.

Authors:  Matteo Biolatti; Valentina Dell'Oste; Sara Pautasso; Jens von Einem; Manfred Marschall; Bodo Plachter; Marisa Gariglio; Marco De Andrea; Santo Landolfo
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

Review 9.  p204, a p200 family protein, as a multifunctional regulator of cell proliferation and differentiation.

Authors:  Yi Luan; Peter Lengyel; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2008-11-21       Impact factor: 7.638

Review 10.  Insights into the pathogenesis of herpes simplex encephalitis from mouse models.

Authors:  Mathieu Mancini; Silvia M Vidal
Journal:  Mamm Genome       Date:  2018-08-23       Impact factor: 2.957

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.